In conclusion, the present study demonstrated that GL-V9 could alleviate DSS-induced colitis and illustrated its anti-oxidative mechanism by up-regulating Trx-1 via activation of AMPK/FOXO3a pathway (Figure 8). The gene discussed is FOXO3; the disease is colitis.